Study title:
Clinical observations with promethazine hydrochloride (PHERNERGAN ELIXIR), in paediatric practice. - Sarma D.N. Dass C.S.- (Indian Med. J., 1978, 72 (9), 156-157.)
- Publication in PHENERGAN Tableelt 25mg, Syrup 1%, Sol inj 2,5%. Syndthesis documentation. French validation dossier 17/06
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROMETHAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: - |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|